Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 5
2006 5
2007 4
2008 8
2009 11
2010 11
2011 13
2012 12
2013 7
2014 11
2015 10
2016 14
2017 12
2018 6
2019 11
2020 14
2021 18
2022 10
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Results by year

Filters applied: . Clear all
Page 1
Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study.
Sewastjanow-Silva M, Xiao L, Gonzalez GN, Wang X, Hofstetter W, Swisher S, Mehran R, Sepesi B, Bhutani MS, Weston B, Coronel E, Waters RE, Rogers JE, Smith J, Lyons L, Reilly N, Yao JC, Ajani JA, Murphy MB. Sewastjanow-Silva M, et al. Among authors: xiao l. Cancers (Basel). 2024 Mar 31;16(7):1378. doi: 10.3390/cancers16071378. Cancers (Basel). 2024. PMID: 38611056 Free PMC article.
Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma.
Makawita S, Lee S, Kong E, Kwong LN, Abouelfetouh Z, Danner De Armas A, Xiao L, Murugesan K, Danziger N, Pavlick D, Korkut A, Ross JS, Javle M. Makawita S, et al. Among authors: xiao l. JCO Precis Oncol. 2024 Mar;8:e2300544. doi: 10.1200/PO.23.00544. JCO Precis Oncol. 2024. PMID: 38547421
Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function.
Hensley PJ, Labbate C, Zganjar A, Howard J, Huelster H, Durdin T, Pham J, Xiao L, Pallauf M, Lombardo K, Glezerman I, Singla N, Raman JD, Coleman J, Spiess PE, Margulis V, Potretzke AM, Matin SF. Hensley PJ, et al. Among authors: xiao l. Eur Urol Oncol. 2024 Feb 1:S2588-9311(24)00030-0. doi: 10.1016/j.euo.2024.01.005. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38307832
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia.
Short NJ, Jabbour E, Jain N, Senapati J, Nasr L, Haddad FG, Li Z, Hsiao YC, Yang JJ, Pemmaraju N, Ohanian M, Wierda WG, Montalban-Bravo G, Borthakur G, Han L, Xiao L, Huang X, Abramova R, Zhao M, Garris R, Konopleva M, Ravandi F, Kantarjian H. Short NJ, et al. Among authors: xiao l. Blood Adv. 2024 Feb 27;8(4):909-915. doi: 10.1182/bloodadvances.2023012231. Blood Adv. 2024. PMID: 38207208 Free PMC article. Clinical Trial.
Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features.
Tran Cao HS, Witt RG, Elsayes KM, Baiomy AA, Xiao L, Palmquist S, Lee SS, Mohamed YI, Mahvash A, Tzeng CD, Chun YS, Koay EJ, Rashid A, Hassan MM, Yao JC, Vauthey JN, Kaseb AO. Tran Cao HS, et al. Among authors: xiao l. Oncologist. 2023 Dec 30:oyad329. doi: 10.1093/oncolo/oyad329. Online ahead of print. Oncologist. 2023. PMID: 38159256 Free article.
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract.
Alhalabi O, Wilson N, Xiao L, Lin Y, Khandelwal J, Moussa MJ, Msaouel P, Navai N, Gao J, Kamat AM, Pilie P, Shah AY, Goswami S, Matin S, Kovitz C, Holla V, Guo C, Czerniak B, Logothetis C, Corn PG, Dinney CPN, Campbell MT, Hansel DE, Tannir NM, Siefker-Radtke AO. Alhalabi O, et al. Among authors: xiao l. Eur Urol Oncol. 2023 Dec;6(6):611-620. doi: 10.1016/j.euo.2023.09.004. Epub 2023 Oct 11. Eur Urol Oncol. 2023. PMID: 37833193
173 results